Picture of Eurofins Scientific SE logo

ERF — Eurofins Scientific SE News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Eurofins 9M Organic Revenue Growth At 4.0%

Oct 21 (Reuters) - Eurofins Scientific SE EUFI.PA:

4.0% ORGANIC REVENUE GROWTH IN 9M 2025; EUROFINS ON TRACK FOR SOLID FULL YEAR GROWTH AND MARGIN EXPANSION

Q3 REVENUES AT EUR 1.80 BILLION

CONFIRMS ITS OBJECTIVES FOR FY 2025 AND FY 2027 AS ANNOUNCED AT FY 2024 RESULTS PRESENTATION

EXPECTS -1.6% REVENUE GROWTH HEADWIND FROM USD

WITH COMPLETION OF SHARE BUYBACK, TOPICS OF INTEREST TO EUROFINS' KEY STAKEHOLDERS IN RECENT QUARTERS HAVE NOW BEEN FULLY ADDRESSED

DUE TO FOREIGN EXCHANGE, IF US DOLLAR/EURO RATE AS OF END OF Q3 HAD HELD FOR WHOLE OF FY 2025, THEN THAT WOULD RESULT IN REPORTED REVENUE FOR FY 2025 BEING AROUND 3% LOWER THAN AT 2024 AVERAGE RATES, AND EBITDA MARGIN AROUND 20BPS LOWER

Source text: ID:nBw8B6vS8a

Further company coverage: EUFI.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Eurofins Scientific SE

See all news